story of the week
Ruxolitinib in Adults With Secondary Hemophagocytic Lymphohistiocytosis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Haematology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Ruxolitinib in Adult Patients With Secondary Haemophagocytic Lymphohistiocytosis: An Open-Label, Single-Centre, Pilot Trial
Lancet Haematol 2019 Sep 16;[EPub Ahead of Print], A Ahmed, SA Merrill, F Alsawah, P Bockenstedt, E Campagnaro, S Devata, SD Gitlin, M Kaminski, A Cusick, T Phillips, S Sood, M Talpaz, A Quiery, PS Boonstra, RA WilcoxFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.